10x Genomics, Inc. TXG Accrued Expenses And Other Liabilities Current
Accrued Expenses And Other Liabilities Current at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept txg:AccruedExpensesAndOtherLiabilitiesCurrent.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s accrued expenses and other liabilities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s accrued expenses and other liabilities current?
- 10x Genomics, Inc. (TXG) reported accrued expenses and other liabilities current of $33.68M in Q1 2026.
- How has 10x Genomics, Inc.'s accrued expenses and other liabilities current changed year-over-year?
- 10x Genomics, Inc.'s accrued expenses and other liabilities current decreased by 26.0% year-over-year, from $45.48M to $33.68M.
- What is the long-term trend for 10x Genomics, Inc.'s accrued expenses and other liabilities current?
- Over 3 years (2022 to 2025), 10x Genomics, Inc.'s accrued expenses and other liabilities current has grown at a -12.6% compound annual growth rate (CAGR), from $59.78M to $39.97M.
- What does accrued expenses and other liabilities current mean?
- This represents the aggregate of short-term obligations that have been incurred but not yet invoiced or paid by the company. It typically includes items such as accrued payroll, employee benefits, taxes, and other operational expenses due within one year. Monitoring this balance helps investors assess the company's short-term liquidity and the timing of its operational cash outflows.